Torque’s Torcort M40 Dry Injection

Product Description

Description: Torque’s Torcort M40 Injection contain methylprednisolone which is a glucocorticoid. It exhibits anti-inflammatory and immunosuppressive properties.

Pharmaceutical Dosage Form: Dry Injection

Route of Administration: Intramuscular/Intravenous

Composition:

Mechanism of Action: Methylprednisolone is used for its anti-inflammatory effects in disorders of many organ systems. It acts in various ways to decrease the inflammatory cycle including dampening the inflammatory cytokine cascade, inhibiting the activation of T cells, decreasing the extravasation of immune cells into the central nervous system, facilitating the apoptosis of activated immune cells, and indirectly decreasing the cytotoxic effects of nitric oxide and tumor necrosis factor alpha.

Indications: Torque’s Torcort M40 Injection is indicated for severe allergic, dermatologic, endocrine, gastrointestinal, hematologic, neoplastic, nervous system, ophthalmic, renal, respiratory, rheumatic disorders unresponsive to conventional treatments, localized inflammatory or hypertrophic lesions (e.g., alopecia areata, keloids, psoriatic plaques, ganglia), acute and chronic joint or soft tissue inflammatory conditions (e.g. arthritis, bursitis, tenosynovitis).

Dosage: As directed by the physician.

Storage: Store protected from light & moisture, at a temperature not exceeding 25°C.

Presentation: 40mg vial

Side effects:

Abdominal distention

Muscle weakness

Loss of muscle mass

Osteoporosis

Hypertension

Fluid & Electrolyte Disturbance

Contraindications: Torque’s Torcort M40 Injection is contraindicated in patients with a known allergy to constituents or excipients, and in premature infants.

Drug Interactions: Torque’s Torcort M40 Injection can cause drug interaction with following drugs:

Oral Anticoagulants

Cyclosporine

Phenobarbital

Phenytoin

Rifampin

Aspirin

Ketoconazole

CYP3A4 Inhibitors

CYP3A4 Inducers

Carbamazepine

Neuromuscular Blocking Agents

Antidiabetics

NSAID’s